HIV vaccines: where we are and where we are going
Open Access
- 1 October 1996
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 348 (9032) , 933-937
- https://doi.org/10.1016/s0140-6736(96)09339-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Toward an Understanding of the Correlates of Protective Immunity to HIV InfectionScience, 1996
- Quantitation of HIV-1 RNA in Plasma Predicts Outcome after SeroconversionAnnals of Internal Medicine, 1995
- Studies in Subjects with Long-Term Nonprogressive Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1995
- Virologic and Immunologic Characterization of Long-Term Survivors of Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1995
- The Natural History of HIV-1 Infection: Virus Load and Virus Phenotype Independent Determinants of Clinical Course?Virology, 1994
- Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIVNature, 1994
- Variations in the Natural History of HIV InfectionAIDS Research and Human Retroviruses, 1994
- The characterization of non-progressorsAIDS, 1993
- Scientific and Social Issues of Human Immunodeficiency Virus Vaccine DevelopmentScience, 1993
- HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infantThe Lancet, 1993